Category Archives: News

713b A Multi-Systems Approach with Big Data from Adverse Event Reporting and Health Records, Clinical Biospecimens, and Experimental Animal Data Reveal That Retinoids Impact Asparaginase-Associated Pancreatitis Outcomes in Leukemic Patients

Asparaginase is a crucial cornerstone chemotherapy for the most common cancer in children, acute lymphoblastic leukemia (ALL). However, a major concern is that 5-10% of all asparaginase users develop the painful, life-threatening complication of pancre… Continue reading

Posted in News | Comments Off on 713b A Multi-Systems Approach with Big Data from Adverse Event Reporting and Health Records, Clinical Biospecimens, and Experimental Animal Data Reveal That Retinoids Impact Asparaginase-Associated Pancreatitis Outcomes in Leukemic Patients

AGA Clinical Practice Update on Strategies to Improve Quality of Screening and Surveillance Colonoscopy: Expert Review

The purpose of this American Gastroenterological Association Institute Clinical Practice Update was to review the available evidence and provide best practice advice regarding strategies to improve the quality of screening and surveillance colonoscopy…. Continue reading

Posted in News | Comments Off on AGA Clinical Practice Update on Strategies to Improve Quality of Screening and Surveillance Colonoscopy: Expert Review

775a Risankizumab Induction Therapy in Patients With Moderate-to-Severe Crohn’s Disease with Intolerance or Inadequate Response to Conventional and/or Biologic Therapy: Results from the Phase 3 ADVANCE Study

Risankizumab (RZB) is a monoclonal antibody against interleukin-23, a key cytokine in the pathogenesis of inflammatory bowel disease. Phase 2 studies have shown efficacy and safety of RZB in patients with Crohn’s disease (CD). Here we report results of… Continue reading

Posted in News | Comments Off on 775a Risankizumab Induction Therapy in Patients With Moderate-to-Severe Crohn’s Disease with Intolerance or Inadequate Response to Conventional and/or Biologic Therapy: Results from the Phase 3 ADVANCE Study

Table of Contents

Posted in News | Comments Off on Table of Contents

Editorial Board

Posted in News | Comments Off on Editorial Board

Elsewhere in The AGA Journals

Posted in News | Comments Off on Elsewhere in The AGA Journals

713a Mining the Gut Microbiota for Novel Procarcinogenic Microbes Reveals Clostridioides difficile as a Driver of Colonic Tumorigenesis

Microbial studies in colorectal cancer (CRC) have largely focused on three species: colibactin-producing E. coli, enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum. However, not all CRC patients harbor these organisms, suggesting that e… Continue reading

Posted in News | Comments Off on 713a Mining the Gut Microbiota for Novel Procarcinogenic Microbes Reveals Clostridioides difficile as a Driver of Colonic Tumorigenesis

Information for Authors and Readers

Gastroenterology is the premiere journal in the field of gastrointestinal disease and is led by an internationally renowned board of editors. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverage … Continue reading

Posted in News | Comments Off on Information for Authors and Readers

713f Histologic Activity in Ulcerative Colitis Patients Achieving Endoscopic Healing is Associated with Higher Rate of Relapse and a Distinct Mucosal Microbial and Transcriptional Profile

Histologic remission (HR) in ulcerative colitis (UC) has been associated with better clinical outcomes. However, this therapeutic target is hard to achieve with the available medications. We aim to assess the relapse-free survival (RFS) of patients wit… Continue reading

Posted in News | Comments Off on 713f Histologic Activity in Ulcerative Colitis Patients Achieving Endoscopic Healing is Associated with Higher Rate of Relapse and a Distinct Mucosal Microbial and Transcriptional Profile

713e Longitudinal Analysis in A HNF4AΔIEC Mouse Colitis Model Reveals that Preclinical Flaring is Associated with Increased Akkermansia muciniphila Levels in the Gut Microbiome

As inflammatory bowel diseases (IBD) develop, the host’s homeostatic relationship with their microbiota changes. Early “preclinical” stages of colitis are relatively understudied, especially with respect to host-microbiota interactions. Intestinal epit… Continue reading

Posted in News | Comments Off on 713e Longitudinal Analysis in A HNF4AΔIEC Mouse Colitis Model Reveals that Preclinical Flaring is Associated with Increased Akkermansia muciniphila Levels in the Gut Microbiome